BRAINBox Solutions

Executive Summary

BRAINBox Solutions is a private diagnostics company headquartered in Raleigh, NC, dedicated to improving the diagnosis and management of traumatic brain injury (TBI). The company has developed a multi-modality approach that combines blood-based biomarker panels with neurocognitive testing to objectively identify mild TBI (mTBI) and predict the likelihood of post-injury symptoms. This integrated test aims to provide emergency departments, sports organizations, and military settings with a rapid, objective tool to assess brain injury, reduce unnecessary CT scans, and guide patient management. By offering both diagnostic and prognostic information, BRAINBox addresses a critical unmet need in a market where current subjective assessments often fail to detect subtle injuries. The company's technology has the potential to become a standard-of-care for mTBI evaluation, improving patient outcomes and reducing healthcare costs. However, as a private entity with limited public disclosures, the investment thesis relies on anticipated regulatory and clinical milestones.

Upcoming Catalysts (preview)

• Q4 2026FDA clearance or De Novo classification for the mTBI diagnostic test55% success
• Q3 2026Publication of key clinical validation study results in a peer-reviewed journal70% success
• Q2 2026Announcement of a commercial partnership or distribution agreement45% success